INTRODUCTION
The dysregulation of mRNA translation is a crucial attribute of the transformed phenotype. Sustained proliferation, one of the hallmarks of cancer 1 , requires increased rates of global protein synthesis, which are achieved through alterations in the expression and activity of specific translation factors, as well as increased ribosome biogenesis and recruitment 2 . Reprogramming of translation is controlled by almost all the major oncogenic signaling pathways, affecting cancer initiation and progression by directing selective translation of specific tumor-promoting mRNAs 3 . Regulation of transcriptspecific translation involves RNA-binding proteins (RBP) capable of recognizing sequence-specific regulatory elements in the 3'UTR, that promote mRNA splicing, stability and translation 4 .
The KH-type splicing regulatory protein (KHSRP, also known as KSRP or FUBP2) is a RBP which binds to mRNA containing an AU-rich element (ARE), the major cis regulatory element responsible for rapid mRNA decay in mammalian cells. AREs are found in the 3′UTRs of short-lived transcripts, such as those encoding cytokines, chemokines, transcription factors, proto-oncogenes, and cell-cycle regulators 5 . KHSRP regulates translation by mediating mRNA decay through direct binding and recruitment of proteins involved in RNA degradation, including the Poly(A)-Specific Ribonuclease (PARN), exosome components and decapping enzymes 6, 7 . Alternatively, KHSRP can regulate translation independently of mRNA decay, either by promoting translational inhibition 8 or indirectly by promoting maturation of selected miRNA precursors 9 . Adding a further layer of complexity, KHSRP also acts as a transcription factor, inducing the expression of the MYC oncogene 10 .
The KHSRP-mediated control of mRNA translation and stability has been extensively studied in the context of innate immunity 8, 11 . Key pro-inflammatory cytokines and chemokines (e.g. IL-6, IL-8, TNF-α, IL-1β), as well as other inflammatory mediators (iNOS and c-fos) are directly targeted and negatively regulated by KHSRP 5, 12 .
Consequently, Khsrp -/-mice are capable of mounting an increased type I interferon (IFN) response and are more resistant to viral infection 13 . However, it is likely that the role of KHSRP is cell type and context dependent, with the balance between KHSRP and other RBP with similar or divergent regulatory effects an important consideration 14 .
In recent years direct evidence for the involvement of KHSRP in cancer has been accumulating. KHSRP contributes to maintaining P19 mouse teratocarcinoma cells in a undifferentiated stem cell-like state, while its knockdown promotes neural differentiation 15 . KHSRP has a multi-faceted role in breast cancer pathogenesis. First of all, KHSRP expression is regulated by the breast cancer susceptibility gene 1 (BRCA1), and BRCA1 mutated tumors overexpress KHSRP 16 . Additionally, the mutant p53-dependent regulation of the aggressive phenotype of triple negative breast cancer is dependent on proteasome-mediated destabilization of KHSRP, and subsequent deregulation of oncosuppressive miRNAs such as let-7a and miR-30c 17 . Furthermore, KHSRP is involved in the TGF-β-dependent regulation of epithelial-to-mesenchymal transition in the mammary gland 18 . Finally, KHSRP has also been implicated in the pathogenesis of small cell lung cancer 19 and osteosarcoma 20 . There is additional indirect evidence to suggest that KHSRP has pleiotropic roles in tumorigenesis, for example through regulation of lipid metabolism or mediating the cellular response to DNA damage 12 .
The role of KHSRP in cancer, however, remains underappreciated, unlike that of other RBPs such as HuR and the cytoplasmic polyadenylation element-binding (CPEB) 21 . This were accessed from a previously described cohort of formalin-fixed paraffin-embedded (FFPE) archival resected tumor tissue samples 29 . Patient details for both cohorts are reported in Table 1 . For immunohistochemistry, TMA sections were incubated with a 1:250 dilution of a rabbit polyclonal anti-KHSRP antibody (HPA034739, Sigma-Aldrich, Saint Louis, MO, USA), and secondary antibody horseradish peroxidase (DAKO Agilent, Santa Clara, CA, USA). Endogenous peroxidase activity was blocked using 3% hydrogen peroxide, and non-specific binding was blocked with casein buffer. Diaminobenzidine was used to visualize staining and sections were counter-stained with haematoxylin, dehydrated and mounted. Stained TMA sections were acquired with a ScanScope XT high throughput scanning system (Aperio Technologies, Leica Biosystems, Buffalo
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Grove, IL, USA) and images were scored by two independent investigators, blinded to the clinical data. Both epithelial and stromal cells were assessed for staining intensity and percent positivity; positive cell count was scored as a continuous variable (0-100%), while intensity was scored using a scale of 0 to 3 (correlating with negative, weak, medium and strong staining, respectively). The mean value of each parameter from the two investigators was calculated, and parameters were averaged from all tissue cores related to the same patient; the two parameters were finally combined using the semiquantitative quickscore method 30 . There was a good correlation between the two assessors (weighted Cohen Kappa coefficient = 0.63). 
RNA isolation and qRT-PCR
Total RNA was isolated from cells using the EZNA Total RNA Kit (Omega, VWR, Radnore, PA, USA). 1 µg of RNA was reverse-transcribed into cDNA using the RT 
Cell-based assays
Cell proliferation was measured by Neutral Red (NR) staining 31 . Real-time cell proliferation was measured using an E-plate 16 (RTCA DP Analyser, xCelligence System, Roche) following the manufacturer's protocol. Cells were seeded at 10,000 cells/well and the recording of the Cell Index (CI) occurred every 15 min during the first six hours, and every hour for the rest of the period. Cells seeded at low density for colony-formation assay were fixed in methanol/citric acid ( 
Gene expression microarray data from this study have been deposited in the Gene
Expression Omnibus under accession number GSE112329. Raw data from the proteomic analysis is publicly available for download on the MassIVE database (ftp://massive.ucsd.edu/MSV000082206). All authors had access to the full data, and have reviewed and approved the final manuscript.
Additional experimental procedures
The generation of stable conditional knock-down cell lines, the gene expression microarray, and the shotgun proteomics analysis of the cell secretome are described in the supplementary methods.
RESULTS

KHSRP is overexpressed in Colorectal cancer
To profile KHSRP expression in CRC, we performed a meta-analysis of CRC microarray datasets from the Oncomine database (www.oncomine.org). KHSRP expression was considering that the three most commonly mutated genes in CRC (APC, TP53 and KRAS) have mutation frequencies of 81%, 60% and 43%, respectively 34 . Collectively, these in silico data provided a framework to support additional investigations into the putative role of KHSRP in the pathogenesis of CRC.
KHSRP is a marker of poor prognosis in colorectal cancer
Next, we investigated KHSRP expression in primary tissue samples to confirm our For a limited number of cases (N=10 patients), data was also available for the corresponding liver metastasis. In both the epithelium and the stroma, the KHSRP score was significantly higher in the metastatic tissue compared to matched normal liver To independently validate the expression of KHSRP in epithelial and stromal compartments from the IHC data, we took advantage of a transcriptomic dataset of 13 CRC and normal colonic mucosa samples, in which epithelial cells and stromal cells had been microdissected by laser capture and profiled separately 37 . KHSRP was significantly overexpressed in the microdissected epithelial tumor compared with tumor stromal areas, and to a lesser extent in the epithelium compared with the stroma of the normal colonic mucosa, in accordance with our IHC data (Figure 3-D) . Although there was a trend in increased KHSRP expression in tumor versus normal tissue for both the epithelium and the stroma, these comparisons were not statistically significant probably due to the low number of samples. Finally, we used transcriptomic data from purified cell populations that were isolated from 14 dissociated human primary CRC samples 38 . (Figure 3-E) .
KHSRP is involved in promoting the growth and survival of CRC cells
Next, we turned to an in vitro model of CRC to investigate the mechanistic role of KHSRP in epithelial cancer cells. We used the SW480 cell line, which was derived from a primary tumor of a moderately differentiated Duke B colon adenocarcinoma 39 . These 
KHSRP regulates cell cycle and affects the tumor-promoting microenvironment
To and intestinal inflammation 43 .
DISCUSSION
The role of KHSRP in cancer, and specifically in the pathogenesis and progression of CRC has not been extensively studied. 45 .
KHSRP expression was not restricted to the epithelial compartment in CRC but was also detected in the stroma. Our IHC data from matched primary and metastatic tissue showed that expression of KHSRP remains unchanged in the epithelial cells upon liver infiltration, but stromal expression is strongly upregulated from a very low basal expression in the normal hepatic stroma. This suggests that invading epithelial cells are capable of modifying the local microenvironment at the secondary site, or alternatively that a local increase in KHSRP expression is pre-existing and might even contribute to the metastatic niche 46 . In fact, KHSRP is involved in the transient expression of the chemokine CX3CL1 in liver epithelial cells in response to IFN-γ stimulation 47 , contributing to the control of cellular homeostasis during inflammation and macrophage infiltration.
To further investigate the role of KHSRP at the molecular level, we used a loss-offunction approach in two cell line models of CRC (SW480 and SW620), which originated from the primary tumor and lymph node metastasis of the same patient There is also considerable interest in the suitability of different members of the translational control machinery as potential therapeutic targets in cancer, although the evidence so far is almost entirely at the preclinical stage 2 . Small molecule inhibition of the RBP HuR in APC Min mice led to a 25% reduction in small intestinal tumor formation, and a concomitant reduction in c-myc protein levels 51 . Another recent report showed that inhibition of mTORC1 using rapamycin caused regression of established APC-deficient intestinal tumors, suggesting that inhibition of translation elongation using existing clinically approved drugs could provide therapeutic benefit for patients at high risk of developing CRC 52 . Our loss-of-function data in in vitro CRC models suggest that KHSRP could also have putative therapeutic implications and warrants further investigation into the suitability of such an approach.
In conclusion, our report sheds light onto the molecular role of KHSRP in colorectal carcinogenesis, providing for the first time comprehensive data in support of a novel protumorigenic role of this RBP in the gut through direct modulation of epithelial cell phenotype and indirect modulation of the tumor microenvironment. 
